Wyeth Loses Bid To Extend Exclusivity For Cydectin
A federal district judge has denied Wyeth Holdings Corp. a 10-month extension on its patent for Cydectin, an animal parasite control medication, saying the U.S. Food and Drug Administration had correctly...To view the full article, register now.
Already a subscriber? Click here to view full article